Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
May 2, 2023 9:39 AM 1 min read

Hush-Hush Healthcare Feud: UnitedHealthcare to Cough Up $91 Million in Arbitration Over Billing Practices

by Vandana Singh Benzinga Editor
Follow

Three arbitrators ruled that UnitedHealthcare Group Inc (NYSE:UNH) must pay damages of $91 million in a 2018 dispute over billing practices that disappeared from public view after the proceedings moved from federal court to a secretive arbitration panel.

Envision Healthcare, a KKR Co Inc (NYSE:KKR)-owned company, sued UnitedHealthcare in 2018, Financial Times reported.

Envision employs doctors for emergency rooms and anaesthesiology departments in several US hospitals.

Also Read: UnitedHealth Posts Q1 Profit Of $5.6B On Strong Optum, Health Plans; Lifts Earnings Outlook.

UnitedHealthcare disagreed with the decision and noted that Envision had asserted many claims that the arbitrators had denied.

The report also added that UnitedHealthcare filed a lawsuit last year, claiming Envision overcharged for routine work by submitting bills indicating that patients would have risked death or permanent impairment unless they had received immediate and complex care. 

In a statement to Financial Times, UnitedHealthcare said it would “continue efforts to protect our members and customers from the small number of bad actors . . . who demand unreasonable and anti-competitive rates for their services and drive up the cost of care for everyone”. 

Envision counters that it is the victim of a long-running campaign by UnitedHealthcare to avoid paying legitimate medical bills.

Price Action: UNH shares are down 0.38% at $493.84 on the last check Tuesday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Large CapNewsHealth CareLegalGeneral
UNH Logo
UNHUnitedHealth Group Inc
$292.65-0.18%
Overview
KKR Logo
KKRKKR & Co Inc
$101.780.05%
UNH Logo
UNHUnitedHealth Group Inc
$292.65-0.18%
Overview
KKR Logo
KKRKKR & Co Inc
$101.780.05%
Comments
Loading...